These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. WHO experience in the therapeutic control of leprosy. Bechelli LM Int J Lepr Other Mycobact Dis; 1971; 39(4):885-9. PubMed ID: 5170476 [No Abstract] [Full Text] [Related]
3. DDS chemoprophylaxis for leprosy in children at Culion Sanitarium Palawan, Philippines. Lara CB Acta Leprol; 1978; (70):35-58. PubMed ID: 104537 [No Abstract] [Full Text] [Related]
4. Leprosy in children aged 0-14 years: report of an 11-year control programme. Keller R; Deen RD Lepr Rev; 1985 Sep; 56(3):239-48. PubMed ID: 4058234 [No Abstract] [Full Text] [Related]
5. Elimination of leprosy: forecasts and projections. Gupte MD Indian J Lepr; 1994; 66(1):19-35. PubMed ID: 7983389 [No Abstract] [Full Text] [Related]
6. Kellersberger Memorial Lecture 1978. Leprosy control--present position and future prospects. Browne SG Ethiop Med J; 1978 Oct; 16(4):169-78. PubMed ID: 744197 [No Abstract] [Full Text] [Related]
8. Leprosy at a turning point? Harboe M Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095 [No Abstract] [Full Text] [Related]
9. The effect of out-patient dapsone in an area of endemic leprosy. Crawford CL Lepr Rev; 1969 Jul; 40(3):159-63. PubMed ID: 5351802 [No Abstract] [Full Text] [Related]
10. [Evaluation of leprosy mass screening campaign in Upper Volta after 10 years of activities (1966-1976)]. Blanc M Acta Leprol; 1978; (73):39-58. PubMed ID: 108912 [No Abstract] [Full Text] [Related]
11. Further results on dapsone-resistant leprosy in Bamako (Mali). Baquillon G; Ferracci C; van Loo G; Pattyn SR Lepr Rev; 1983 Mar; 54(1):19-21. PubMed ID: 6843273 [No Abstract] [Full Text] [Related]
12. WHO expert committee on leprosy. World Health Organ Tech Rep Ser; 1970; 459():3-31. PubMed ID: 4993944 [No Abstract] [Full Text] [Related]
17. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results]. Bourland J; Van Loo L; Pattyn SR Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995 [No Abstract] [Full Text] [Related]
18. [Survey on the prevalence rate of dapsone-resistant leprosy in the Yangzhou district]. Li WZ; Ye GY; Wang HY; Tao MB; Ma B; Zhang YF Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Feb; 6(1):59-61. PubMed ID: 6238701 [No Abstract] [Full Text] [Related]
19. Leprosy control in Shandong Province, China, 1955-1983; some epidemiological features. Li HY; Pan YL; Wang Y Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):79-85. PubMed ID: 3998564 [TBL] [Abstract][Full Text] [Related]
20. Risk of infection in leprosy. Figueredo N; Balkrishnan V Lepr Rev; 1967 Apr; 38(2):87-96. PubMed ID: 6045744 [No Abstract] [Full Text] [Related] [Next] [New Search]